{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:43:01Z","timestamp":1787625781397,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Vitamin C (Vit C) and iron metabolism are closely related to metabolic disorders. However, the relation between iron storage protein ferritin and Vit C has not been elucidated. We aimed to investigate the crosstalk between Vit C and ferritin and its implications on non-alcoholic fatty liver disease (NAFLD). Clinical information of 3,614 subjects was obtained from the NHANES Public Data 2017\u20132018. FibroScan data, which estimates liver steatosis and fibrosis and Vit C, were selected to assess factors influencing NAFLD in this cross-sectional study. Ferritin and Vit C among different categories of liver steatosis and fibrosis were assessed by CAP and E value. Logistic regression and RCS models were used to analyze the correlations. <jats:italic>In vitro<\/jats:italic> study in hepG2 were conducted to validate the regulations. Ferritin increased while Vit C decreased with more severe hepatic steatosis and hepatic fibrosis (all <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Logistic regression models indicated that increased serum ferritin was a risk factor for NAFLD while increased Vit C was a protective factor for NAFLD and hepatic fibrosis after adjusting the continuous and categorical variables. Vitamin C was negatively associated with ferritin. Further mediation analysis identified that ferritin mediates the impact of Vit C on NAFLD (<jats:italic>P<\/jats:italic> &amp;lt; 0.05) and cirrhosis (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The experiments on cellular level suggested Vit C alleviated PA\/OA induced steatosis and maintains iron homeostasis through inhibiting PA\/OA induced upregulation of iron bound protein ferritin and labile iron pool (LIP) induction in hepG2 cells. In conclusion, Vit C was a protective factor, whereas ferritin was a risk factor for hepatic steatosis and fibrosis. Vitamin C alleviated NAFLD and maintained iron homeostasis via ferritin suppression and LIP induction.<\/jats:p>","DOI":"10.3389\/fnut.2022.952056","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:49:00Z","timestamp":1662637740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhengyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin Liver Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1080\/10408398.2015.1117413","article-title":"Association between vitamin deficiency and metabolic disorders related to obesity","volume":"57","author":"Thomas-Vald\u00e9s","year":"2017","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.3390\/nu6125473","article-title":"Does vitamin C deficiency promote fatty liver disease development?","volume":"6","author":"Ipsen","year":"2014","journal-title":"Nutrients."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.dld.2019.06.005","article-title":"Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease","volume":"51","author":"Ivancovsky-Wajcman","year":"2019","journal-title":"Dig Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0147985","DOI":"10.1371\/journal.pone.0147985","article-title":"Association between dietary vitamin C Intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"745609","DOI":"10.3389\/fnut.2021.745609","article-title":"Effects of oral vitamin C supplementation on liver health and associated parameters in patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"8","author":"He","year":"2021","journal-title":"Front Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2891-2-9","article-title":"Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats","volume":"2","author":"Oliveira","year":"2003","journal-title":"Nutr J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41366-018-0212-0","article-title":"Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor alpha in high-fat-diet-fed C57BL\/6J mice","volume":"43","author":"Lee","year":"2019","journal-title":"Int J Obes (Lond)."},{"key":"B10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","article-title":"Effects of iron overload on chronic metabolic diseases","volume":"2","author":"Fernandez-Real","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"mfab021","DOI":"10.1093\/mtomcs\/mfab021","article-title":"Chemistry and biology of ferritin","volume":"13","author":"Plays","year":"2021","journal-title":"Metallomics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fendo.2020.00340","article-title":"Serum ferritin correlates with liver fat in male adolescents with obesity","volume":"11","author":"Morwald","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jhep.2006.09.018","article-title":"NAFLD and hyperinsulinemia are major determinants of serum ferritin levels","volume":"46","author":"Zelber-Sagi","year":"2007","journal-title":"J Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/diagnostics10110917","article-title":"Predictive value of serum ferritin in combination with alanine aminotransferase and glucose levels for noninvasive assessment of NAFLD: Fatty Liver in Obesity (FLiO) study","volume":"10","author":"Galarregui","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.3748\/wjg.v22.i36.8112","article-title":"Iron and non-alcoholic fatty liver disease","volume":"22","author":"Britton","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"146563","DOI":"10.1016\/j.scitotenv.2021.146563","article-title":"Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: a population-based study","volume":"780","author":"Hu","year":"2021","journal-title":"Sci Total Environ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1751-7176.2009.00179.x","article-title":"Definition and classification of hypertension: an update","volume":"11","author":"Giles","year":"2009","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41430-021-00870-0","article-title":"Low 25-hydroxyvitamin D is associated with arterial stiffness in Chinese with type 2 diabetes mellitus","volume":"75","author":"Ma","year":"2021","journal-title":"Eur J Clin Nutr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","year":"2020","journal-title":"Diabetes Care."},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clnu.2008.10.006","article-title":"Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference","volume":"28","author":"Onat","year":"2009","journal-title":"Clin Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7762\/cnr.2014.3.1.56","article-title":"Comparison of nutrient intake and diet quality between hyperuricemia subjects and controls in Korea","volume":"3","author":"Ryu","year":"2014","journal-title":"Clin Nutr Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/cyto.a.20491","article-title":"Flow cytometry measurement of the labile iron pool in human hematopoietic cells","volume":"73","author":"Prus","year":"2008","journal-title":"Cytometry A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"111329","DOI":"10.1016\/j.fct.2020.111329","article-title":"Impaired ferritinophagy flux induced by high fat diet mediates hepatic insulin resistance via endoplasmic reticulum stress","volume":"140","author":"Jiang","year":"2020","journal-title":"Food Chem Toxicol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","author":"Baron","year":"1986","journal-title":"J Pers Soc Psychol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bcp.12899","article-title":"The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease","volume":"83","author":"Del Ben","year":"2017","journal-title":"Br J Clin Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism."},{"key":"B29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/diagnostics10060395","article-title":"Could SCGF-Beta levels be associated with inflammation markers and insulin resistance in male patients suffering from obesity-related NAFLD?","volume":"10","author":"Tarantino","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/JCMA.0000000000000009","article-title":"Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients","volume":"82","author":"Batsaikhan","year":"2019","journal-title":"J Chin Med Assoc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000228547","article-title":"Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C","volume":"52","author":"Won","year":"2009","journal-title":"Intervirology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/liv.13395","article-title":"Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis","volume":"37","author":"Wood","year":"2017","journal-title":"Liver Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12072-018-9892-8","article-title":"Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population","volume":"13","author":"Jung","year":"2019","journal-title":"Hepatol Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/liv.14096","article-title":"Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease","volume":"39","author":"Buzzetti","year":"2019","journal-title":"Liver Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/odi.12446","article-title":"Vitamin C: the known and the unknown and goldilocks","volume":"22","author":"Padayatty","year":"2016","journal-title":"Oral Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-nutr-071714-034228","article-title":"Regulation of the epigenome by vitamin C","volume":"35","author":"Young","year":"2015","journal-title":"Annu Rev Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/nu9111211","article-title":"Vitamin C and immune function","volume":"9","author":"Carr","year":"2017","journal-title":"Nutrients."},{"key":"B39","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.biopha.2020.110792","article-title":"Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice","volume":"131","author":"Zeng","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcme.2008.01.002","article-title":"Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials","volume":"7","author":"McRae","year":"2008","journal-title":"J Chiropr Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1113\/expphysiol.2007.035147","article-title":"Human cholesterol metabolism and therapeutic molecules","volume":"93","author":"Charlton-Menys","year":"2008","journal-title":"Exp Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ajpath.2021.05.020","article-title":"Vitamin C deficiency inhibits nonalcoholic fatty liver disease progression through impaired de novo lipogenesis","volume":"191","author":"Lee","year":"2021","journal-title":"Am J Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2018.09.041","article-title":"Ascorbate and ferritin interactions: consequences for iron release in vitro and in vivo and implications for inflammation","volume":"133","author":"Badu-Boateng","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2017.03.015","article-title":"Labile iron potentiates ascorbate-dependent reduction and mobilization of ferritin iron","volume":"108","author":"Badu-Boateng","year":"2017","journal-title":"Free Radic Biol Med."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.952056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:49:05Z","timestamp":1662637745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.952056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":44,"alternative-id":["10.3389\/fnut.2022.952056"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.952056","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"952056"}}